BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30779881)

  • 1. Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity.
    Chhabra Y; Nelson CN; Plescher M; Barclay JL; Smith AG; Andrikopoulos S; Mangiafico S; Waxman DJ; Brooks AJ; Waters MJ
    FASEB J; 2019 May; 33(5):6412-6430. PubMed ID: 30779881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
    Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
    J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine adiponectin receptor 1 transgene resists high-fat/sucrose diet-induced weight gain, hepatosteatosis and insulin resistance in mice.
    Liu BH; Lin YY; Wang YC; Huang CW; Chen CC; Wu SC; Mersmann HJ; Cheng WT; Ding ST
    Exp Anim; 2013; 62(4):347-60. PubMed ID: 24172199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4.
    Liu J; Nie C; Xue L; Yan Y; Liu S; Sun J; Fan M; Qian H; Ying H; Wang L; Li Y
    Theranostics; 2021; 11(17):8283-8300. PubMed ID: 34373742
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neurons.
    Cady G; Landeryou T; Garratt M; Kopchick JJ; Qi N; Garcia-Galiano D; Elias CF; Myers MG; Miller RA; Sandoval DA; Sadagurski M
    Mol Metab; 2017 May; 6(5):393-405. PubMed ID: 28462074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice.
    Vecchi C; Montosi G; Garuti C; Corradini E; Sabelli M; Canali S; Pietrangelo A
    Gastroenterology; 2014 Apr; 146(4):1060-9. PubMed ID: 24361124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
    Mueller KM; Kornfeld JW; Friedbichler K; Blaas L; Egger G; Esterbauer H; Hasselblatt P; Schlederer M; Haindl S; Wagner KU; Engblom D; Haemmerle G; Kratky D; Sexl V; Kenner L; Kozlov AV; Terracciano L; Zechner R; Schuetz G; Casanova E; Pospisilik JA; Heim MH; Moriggl R
    Hepatology; 2011 Oct; 54(4):1398-409. PubMed ID: 21725989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer.
    Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R
    Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
    Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
    J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis.
    Vázquez-Borrego MC; Del Río-Moreno M; Pyatkov M; Sarmento-Cabral A; Mahmood M; Pelke N; Wnek M; Cordoba-Chacon J; Waxman DJ; Puchowicz MA; McGuinness OP; Kineman RD
    Metabolism; 2023 Jul; 144():155589. PubMed ID: 37182789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease.
    Valenti L; Mendoza RM; Rametta R; Maggioni M; Kitajewski C; Shawber CJ; Pajvani UB
    Diabetes; 2013 Dec; 62(12):4052-62. PubMed ID: 23990360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis.
    DiFedele LM; He J; Bonkowski EL; Han X; Held MA; Bohan A; Menon RK; Denson LA
    Gastroenterology; 2005 May; 128(5):1278-91. PubMed ID: 15887111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal-jejunal bypass surgery up-regulates the expression of the hepatic insulin signaling proteins and the key regulatory enzymes of intestinal gluconeogenesis in diabetic Goto-Kakizaki rats.
    Sun D; Wang K; Yan Z; Zhang G; Liu S; Liu F; Hu C; Hu S
    Obes Surg; 2013 Nov; 23(11):1734-42. PubMed ID: 23700236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-specific deletion of signal transducer and activator of transcription 5 augments lipid accumulation in skeletal muscle and liver of mice in response to high-fat diet.
    Baik M; Lee MS; Kang HJ; Park SJ; Piao MY; Nguyen TH; Hennighausen L
    Eur J Nutr; 2017 Mar; 56(2):569-579. PubMed ID: 26582580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of reduced growth hormone action in fatty liver disease.
    Rufinatscha K; Ress C; Folie S; Haas S; Salzmann K; Moser P; Dobner J; Weiss G; Iruzubieta P; Arias-Loste MT; Crespo J; Tilg H; Kaser S
    Hepatol Int; 2018 Sep; 12(5):474-481. PubMed ID: 30206761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.
    Barclay JL; Nelson CN; Ishikawa M; Murray LA; Kerr LM; McPhee TR; Powell EE; Waters MJ
    Endocrinology; 2011 Jan; 152(1):181-92. PubMed ID: 21084450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.
    Gan Y; Buckels A; Liu Y; Zhang Y; Paterson AJ; Jiang J; Zinn KR; Frank SJ
    Mol Endocrinol; 2014 Nov; 28(11):1841-54. PubMed ID: 25211187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
    Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
    Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2.
    Zhang L; Li X; Zhang N; Yang X; Hou T; Fu W; Yuan F; Wang L; Wen H; Tian Y; Zhang H; Lu X; Zhu WG
    Diabetes; 2020 Sep; 69(9):1887-1902. PubMed ID: 32641353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat diet-induced metabolic deterioration.
    Vijayakumar A; Wu Y; Sun H; Li X; Jeddy Z; Liu C; Schwartz GJ; Yakar S; LeRoith D
    Diabetes; 2012 Jan; 61(1):94-103. PubMed ID: 22187377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.